Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02889419
Other study ID # RC-P0045
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date January 2017
Est. completion date June 2020

Study information

Verified date August 2018
Source Lille Catholic University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

KML is a multicenter, prospective, uncontrolled and before/after study. The study aims to estimate if the use of Selfia ® adapted underwear reduces the necessary duration for the realization of self-catheterisation (SC) for patients affected by multiple sclerosis with severe to moderate disability.

Secondly, the study aims to :

- Estimate the effect of underwear on quality of life, tiredness linked to the act, comfort in the realization of SC, complications with SC, third party intervention ;

- Collect patients' opinion on the use of the underwear SELFIA ® at the end of the 2nd week of evaluation ;

- Measure if the patient reused underwear and if he bought it at 6 months and at 1 year


Description:

Bladder-sphincter disorders affect 80 % of the patients suffering from multiple sclerosis (MS) after 10 years of evolution and urinary self-catheterization (SC) are part of the therapeutic arsenal.

SC involves different steps: the preparation of the material, the undressing, the transfer on toilets, the technical gesture and the dressing. Recommendations of good practice of SC of the French Society of Physical Medicine and Rehabilitation evoke the necessity to adapt the wardrobe but without precision on the definition of this adaptation.

Adapted underwear exists for patients with a disability and is accessible for the general public. However, no clinical trial has ever evaluated their real practical interest for disabled patients realizing SC.

These undergarments, according to our experience, are very ingenious and would bring a real comfort in everyday life from patients with a disability.

In case of SC, this underwear would facilitate and shorten the time dedicated to this technique, especially as SC are realized on average 6 times a day for patients already affected in their movements because of their initial handicap.

The adapted underwear could bring an ease and a speed of dressing / undressing, allow an easier and faster access to the urinary meatus and a limitation of manipulations and mobilizations of the patient allowing an energy saving.

Moreover, disabled patients request concrete advice from health professionals on everyday life problems such as dressing / undressing. Therefore it seemed interesting to estimate the benefits of using adapted underwear for the realization of SC for patients affected by MS with severe to moderate disability (EDSS 6 - 7.5) affecting everyday life activities.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date June 2020
Est. primary completion date June 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients with multiple sclerosis (MS) according to McDonald criteria

- At least 18 years old

- Self-catheterization for at least 3 months

- Expended Disability Status Scale (EDSS) between 6.0 and 7.5

- Informed consent

- Coverage of the social insurance

Exclusion Criteria:

- MS relapse in the previous month

- Patient hospitalized in short stay or aftercare departments, no matter the reason

- Morbid obesity (BMI superior to 35)

- Understanding disorders preventing an informed consent

- EDSS inferior to 6.0 or superior to 7.5

- Patient with home bladder catheter

- No capacity to provide a self-catheterisation

- Age under 18 years

- Pregnant or breast-feeding woman

- Patient under legal protection

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Evaluation of underwear Selfia®
Patients are evaluated for a week using their usual underwear for the realization of SC. At the end of the week, they receive Selfia ® adaptated underwear and they use it for one week for a new evaluation. Finally, underwear will be given to patients and during follow-up consultations in routine at 6 months and 1 year, he will be asked if they reused or bought underwear.

Locations

Country Name City State
France Clinique Saint-Augustin Bordeaux
France Hôpital Swynghedauw - CHRU de Lille Lille
France Groupement des Hôpitaux de l'Institut Catholique de Lille Lomme Nord Pas-de-Calais
France Cabinet médical de Neurologie Lyon
France Hôpital Saint-Jacques - CHU Nantes Nantes
France Pôle MPR Saint Hélier Rennes

Sponsors (1)

Lead Sponsor Collaborator
Lille Catholic University

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Average time spend for the realization of a self-catheterisation, from undressing to dressing, measured by a chronometer provided to the patient 17 days
Secondary Measure of the quality of life Specific scale adapted for the studied population: Qualiveen (self-questionnaire for MS patients with urinary disorders) 17 days
Secondary Measure of fatigue for every SC EVA scale 17 days
Secondary Comfort linked to SC EVA scale for pain linked to undressing / dressing 17 days
Secondary Consequences from SC complications Number of bleeding, EVA scale for the pain linked to the introduction / withdraw of the urinary catheter, 17 days
Secondary Number of documented urinary infections 17 days
Secondary Number of self-catheterisation or hetero-catheterisation per day 17 days
Secondary Opinion of the patient (favorable/non favorable) on the use of underwear Selfia ® at 6 months and at 1 year
Secondary Re-use (yes/no) of underwear with or without purchase (yes/no) at 6 months and at 1 year
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03269175 - BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies Phase 4